Tagged esophageal-cancer

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus
Press Release

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus

 By combining Deciphex's unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI. Read More
Cernostics Announces Blinded, Independent Validation of TissueCypher(R) Performance for Predicting Risk of Progression to Esophageal Cancer in Patients With Non-Dysplastic BE
Press Release

Cernostics Announces Blinded, Independent Validation of TissueCypher(R) Performance for Predicting Risk of Progression to Esophageal Cancer in Patients With Non-Dysplastic BE

 Study further validates TissueCypher(R) as the first and only precision medicine test proven to provide actionable data for predicting patient progression to high-grade dysplasia and esophageal adenocarcinoma Read More
Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE
Press Release

Cernostics Announces Groundbreaking Data Demonstrating TissueCypher Performance for Predicting Risk of Progression to EAC in Patients With Non-Dysplastic BE

 First-of-its-kind precision medicine test for esophageal pinch biopsies identifies high-risk, non-dysplastic BE patients that progress to EAC at rates higher than expert-confirmed LGD Read More
TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences
Press Release

TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences

 Data presented at ACG, UEGW illustrates the fourth independent validation of TissueCypher performance for risk stratifying non-dysplastic Barrett's esophagus (NDBE) patients; expands indication for testing low-grade dysplasia (LGD) Read More
The Center for Digestive Medicine Talks About the Benefits of Receiving an Upper Endoscopy
Press Release

The Center for Digestive Medicine Talks About the Benefits of Receiving an Upper Endoscopy

 Read More
Press Release

April is Esophageal Cancer Awareness Month

 The Salgi Esophageal Cancer Research Foundation is working to raise awareness of esophageal cancer; a deadly cancer that is on the increase. Read More
Press Release

Innovative Procedure to Treat Barrett's Esophagus Now Available at Ocean Medical Center

 Innovative Procedure to Treat Barrett's Esophagus helps decrease risk of esophageal cancer. Read More